Concepedia

Nitin Jain

NJ

Statistics

Publications

284

Citations

17.1K

H-Index

70

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, Irvine

Dana-Farber Cancer Institute

University of California, Irvine Medical Center

Nitin Jain is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

2003–2025

284

Publications

284

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Nitin Jain, Michael J. Keating, Philip A. Thompson et al. · New England Journal of Medicine · 2019 · 491 citations · Full text

Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies

Courtney D. DiNardo, Caitlin R. Rausch, Christopher B. Benton et al. · American Journal of Hematology · 2017 · 429 citations · Full text

Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults

Nitin Jain, Kathryn G. Roberts, Elias Jabbour et al. · Blood · 2016 · 376 citations · Full text

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

, , +9

Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype

Nitin Jain, Audrey Lamb, Susan O’Brien et al. · Blood · 2016 · 338 citations · Full text

Rows per page

1–5 of 284